D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIVO
3176
PUT
DELISTED
Tivo Inc
TIVO
| $369K | ﹤0.01% |
+50,000
| New | +$401K |
|
3177
CALL
CACI
CACI
$10.8B
| $368K | ﹤0.01% |
1,800
| – | – |
|
3178
Moderna
MRNA
$21.5B
| $368K | ﹤0.01% |
+25,128
| New | +$540K |
|
3179
CALL
Omega Healthcare
OHI
$15.4B
| $368K | ﹤0.01% |
10,000
| – | – |
|
3180
Power Integrations
POWI
$3.54B
| $368K | ﹤0.01% |
9,182
+2,394
| +35% | +$87.5K |
|
|
ACRE
3181
Ares Commercial Real Estate
ACRE
$252M
| $367K | ﹤0.01% |
24,721
+6,341
| +34% | +$95.8K |
|
3182
Stewart Information Services
STC
$2.05B
| $367K | ﹤0.01% |
9,067
-4,868
| -35% | -$207K |
|
|
BNY
3183
PUT
Bank of New York Mellon
BNY
$108B
| $366K | ﹤0.01% |
+8,300
| New | +$390K |
|
3184
SolarEdge
SEDG
$2.59B
| $366K | ﹤0.01% |
5,863
-7,717
| -57% | -$389K |
|
|
WPG
3185
DELISTED
Washington Prime Group Inc.
WPG
| $366K | ﹤0.01% |
10,647
+4,079
| +62% | +$167K |
|
3186
PUT
Automatic Data Processing
ADP
$100B
| $364K | ﹤0.01% |
+2,200
| New | +$357K |
|
3187
CALL
S&P Global
SPGI
$126B
| $364K | ﹤0.01% |
+1,600
| New | +$349K |
|
3188
Winmark
WINA
$1.19B
| $364K | ﹤0.01% |
2,103
| – | – |
|
|
ADAM
3189
Adamas Trust
ADAM
$777M
| $363K | ﹤0.01% |
+14,623
| New | +$361K |
|
|
CVA
3190
DELISTED
Covanta Holding Corporation
CVA
| $361K | ﹤0.01% |
20,161
-1,631
| -7% | -$28.8K |
|
3191
International Flavors & Fragrances
IFF
$19.4B
| $359K | ﹤0.01% |
+2,474
| New | +$344K |
|
3192
Parker-Hannifin
PH
$125B
| $357K | ﹤0.01% |
2,100
-1,700
| -45% | -$293K |
|
|
AVYA
3193
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $357K | ﹤0.01% |
+30,000
| New | +$459K |
|
|
MLNT
3194
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $357K | ﹤0.01% |
+53,672
| New | +$204K |
|
3195
City Holding Co
CHCO
$1.97B
| $356K | ﹤0.01% |
4,662
-778
| -14% | -$59.9K |
|
3196
Sturm, Ruger & Co
RGR
$610M
| $355K | ﹤0.01% |
6,514
-9,460
| -59% | -$503K |
|
3197
CALL
Valmont Industries
VMI
$9.44B
| $355K | ﹤0.01% |
2,800
-7,500
| -73% | -$935K |
|
3198
BWX Technologies
BWXT
$16B
| $354K | ﹤0.01% |
6,788
-12,812
| -65% | -$640K |
|
3199
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $354K | ﹤0.01% |
26,134
-69,122
| -73% | -$1.07M |
|
3200
Globe Life
GL
$13.5B
| $353K | ﹤0.01% |
3,951
-1,763
| -31% | -$154K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.